Clinical Trial Update: Intracameral Versus Intravitreal Bevacizumab Injection in NVG: RCT [NA]

View source ↗

Summary

Ongoing randomized trial comparing intracameral versus intravitreal bevacizumab for neovascular glaucoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Glaucoma

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Prince of Songkla University | Conditions: Glaucoma, Neovascular, Vascular Endothelial Growth Factor Overexpression | NA | Status: RECRUITING